Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00032227 · ClinicalTrials.gov registry record · NA
Carpal Tunnel Syndrome: Diagnosis and Treatment Trial
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 116
- Enrollment target
NCT00032227: Completed NA study, sponsored by University of Washington.
NCT00032227 is a NA study that has completed, run by University of Washington. The registered enrollment target is 116 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00032227, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
Study Summary
The Carpal Tunnel Syndrome Diagnosis and Treatment Trial is project #1 of the Multidisciplinary Clinical Research Center focused on upper extremity pain. It is a randomized trial comparing surgical and nonsurgical treatments for patients with early, mild to moderate carpal tunnel syndrome. In addition the study will evaluate the ability of a new magnetic resonance (MR) technique at predicting who will likely benefit from carpal tunnel syndrome (CTS) surgery.
Interventions
- PROCEDURE Early Carpal Tunnel Release for Mild or Moderate CTS
- OTHER MR Nerve Imaging for CTS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2002-08 |
| Est. Completion | 2008-04 |
| Phase | NA |
What the finished NCT00032227 record still lists
NCT00032227 is an interventional study that assigns participants to a tested intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Early Carpal Tunnel Release for Mild or Moderate CTS is the first listed.
NCT00032227 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00032227 about?
NCT00032227 is a clinical study titled "Carpal Tunnel Syndrome: Diagnosis and Treatment Trial". The Carpal Tunnel Syndrome Diagnosis and Treatment Trial is project #1 of the Multidisciplinary Clinical Research Center focused on upper extremity pain. It is a randomized trial comparing surgical and nonsurgical treatments for patients with early, mild to moderate carpal tunnel syndrome. In additi...
What is the current status of trial NCT00032227?
This trial is currently completed. It is a NA study. The enrollment target is 116 participants. The study started on 2002-08. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00032227?
The interventions under investigation include: Early Carpal Tunnel Release for Mild or Moderate CTS (PROCEDURE), MR Nerve Imaging for CTS (OTHER).
Who is sponsoring clinical trial NCT00032227?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00032227's enrollment target sits among peer trials
116 808th of 2000 higher than 1,191 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03014687 · 116 participants · Phase 4
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
- NCT03214562 · 116 participants · Phase 1
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- NCT03847467 · 116 participants · Phase 1
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- NCT04222413 · 116 participants · Phase 1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia